The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

The Trump administration's freeze on communications, travel, and diversity efforts has sowed chaos across federal health ...

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

President Trump has ended the federal security detail for Anthony Fauci, the infectious disease expert who advised him on the ...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...

Scientists nationwide said the cancellation of NIH grant reviews has thrown early-career scientists into limbo ...

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. STAT is ...

Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...